Completed PHASE4 INTERVENTIONAL 2-arm NCT03186742

Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy

Effects of Eplerenone on Left Ventricular Hypertrophy in Patients With Resistant Hypertension and Obstructive Sleep Apnoea

Sponsor: Poznan University of Medical Sciences

Conditions Hypertension,Essential Left Ventricular Hypertrophy Obstructive Sleep Apnea

Interventions Eplerenone 50 mg Tab

Updated 5 times since 2017 Last updated: Jun 13, 2017 Started: Jul 1, 2014 Primary completion: Jan 1, 2017 Completion: Jun 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypertension,Essential and Left Ventricular Hypertrophy, this trial is completed. The trial is conducted by Poznan University of Medical Sciences and has accumulated 5 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jul 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Poznan University of Medical Sciences

Data source: Poznan University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.